These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21914028)

  • 1. Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation.
    Friedman PA; Holmes DR
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1184-91. PubMed ID: 21914028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations.
    Dave AS; Valderrábano M
    Methodist Debakey Cardiovasc J; 2017; 13(3):106-113. PubMed ID: 29743994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical closure devices for atrial fibrillation.
    Price MJ; Holmes DR
    Trends Cardiovasc Med; 2014 Aug; 24(6):225-31. PubMed ID: 25066488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left atrial appendage occlusion: New perspectives for the method.
    Gorczyca-Michta I; Wożakowska-Kapłon B
    Cardiol J; 2017; 24(5):554-562. PubMed ID: 28281734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in risk of stroke and bleeding after left atrial appendage closure with LARIAT device in patients with increased risk of stroke and bleeding: Long term results.
    Litwinowicz R; Bartus M; Kapelak B; Suwalski P; Lakkireddy D; Lee RJ; Bartus K
    Catheter Cardiovasc Interv; 2019 Nov; 94(6):837-842. PubMed ID: 30884101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage devices for stroke prevention in atrial fibrillation.
    Hussain SK; Malhotra R; DiMarco JP
    J Cardiovasc Transl Res; 2014 Jun; 7(4):458-64. PubMed ID: 24789763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Bajwa RJ; Kovell L; Resar JR; Arbab-Zadeh A; Mandal K; Calkins H; Berger RD
    Clin Cardiol; 2017 Oct; 40(10):825-831. PubMed ID: 28750152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Appendage Occlusion for Stroke Prevention.
    Chanda A; Reilly JP
    Prog Cardiovasc Dis; 2017; 59(6):626-635. PubMed ID: 28457791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous closure of the left atrial appendage for stroke prevention].
    Loupis AM; De Backer O; Ihlemann N; Rosenberg TS; Franzen OW; Søndergaard L
    Ugeskr Laeger; 2014 Sep; 176(38):. PubMed ID: 25294196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage exclusion: state-of-the-art.
    Cruz-Gonzalez I; Yan BP; Lam YY
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):806-13. PubMed ID: 20088009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation.
    Valderrábano M; Price MJ
    Methodist Debakey Cardiovasc J; 2015; 11(2):94-9. PubMed ID: 26306126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation.
    Bedeir K; Holmes DR; Cox JL; Ramlawi B
    J Thorac Cardiovasc Surg; 2017 May; 153(5):1097-1105. PubMed ID: 28262290
    [No Abstract]   [Full Text] [Related]  

  • 20. Cather-based approaches to stroke prevention in atrial fibrillation.
    Kapur S; Mansour M
    Curr Cardiol Rep; 2013 Nov; 15(11):419. PubMed ID: 24057773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.